CA9 antibody (AA 38-414)
Quick Overview for CA9 antibody (AA 38-414) (ABIN7139767)
Target
See all CA9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 38-414
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Peptide sequence from Human Carbonic anhydrase 9 protein (38-414AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: IHC:1:200-1:500,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CA9 (Carbonic Anhydrase IX (CA9))
-
Alternative Name
- CA9
-
Background
-
Background: Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia.
Aliases: CA-IX antibody, CA9 antibody, CAH9_HUMAN antibody, CAIX antibody, Carbonate dehydratase IX antibody, Carbonic anhydrase 9 antibody, Carbonic anhydrase IX antibody, Carbonic dehydratase antibody, G250 antibody, Membrane antigen MN antibody, MN antibody, P54/58N antibody, pMW1 antibody, RCC associated protein G250 antibody, RCC-associated antigen G250 antibody, Renal cell carcinoma-associated antigen G250 antibody
-
UniProt
- Q16790
Target
-